###begin article-title 0
Toll-like receptor polymorphisms in malaria-endemic populations
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 131 153 131 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 131 152 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Toll-like receptors (TLR) and related downstream signaling pathways of innate immunity have been implicated in the pathogenesis of Plasmodium falciparum malaria. Because of their potential role in malaria pathogenesis, polymorphisms in these genes may be under selective pressure in populations where this infectious disease is endemic.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 125 141 125 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2, TLR4, TLR9</italic>
###xml 143 176 143 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MyD88-Adaptor Like Protein (MAL) </italic>
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
A post-PCR Ligation Detection Reaction-Fluorescent Microsphere Assay (LDR-FMA) was developed to determine the frequencies of TLR2, TLR4, TLR9, MyD88-Adaptor Like Protein (MAL) single nucleotide polymorphisms (SNPs), and TLR2 length polymorphisms in 170 residents of two regions of Kenya where malaria transmission is stable and high (holoendemic) or episodic and low, 346 residents of a malaria holoendemic region of Papua New Guinea, and 261 residents of North America of self-identified ethnicity.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 147 181 147 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glucose-6-phoshpate dehydrogenase </italic>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6PD</italic>
###xml 192 211 192 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hemoglobin S (HbS) </italic>
###xml 334 350 334 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2, TLR4, TLR9</italic>
###xml 356 360 356 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 556 561 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
The difference in historical malaria exposure between the two Kenyan sites has significantly increased the frequency of malaria protective alleles glucose-6-phoshpate dehydrogenase (G6PD) and Hemoglobin S (HbS) in the holoendemic site compared to the episodic transmission site. However, this study detected no such difference in the TLR2, TLR4, TLR9, and MAL allele frequencies between the two study sites. All polymorphisms were in Hardy Weinberg Equilibrium in the Kenyan and Papua New Guinean populations. TLR9 SNPs and length polymorphisms within the TLR2 5' untranslated region were the only mutant alleles present at a frequency greater than 10% in all populations.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 23 39 23 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2, TLR4, TLR9</italic>
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
Similar frequencies of TLR2, TLR4, TLR9, and MAL genetic polymorphisms in populations with different histories of malaria exposure suggest that these innate immune pathways have not been under strong selective pressure by malaria. Genotype frequencies are consistent with Hardy-Weinberg Equilibrium and the Neutral Theory, suggesting that genetic drift has influenced allele frequencies to a greater extent than selective pressure from malaria or any other infectious agents in these populations.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 210 232 210 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 652 655 652 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 875 876 875 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 877 878 877 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 210 231 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 335 343 <span type="species:ncbi:9606">children</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
Every year 350-500 million cases of malaria occur worldwide, and up to 2.5 million of these individuals are estimated to die, mainly from neurologic complications, severe anaemia or respiratory distress due to Plasmodium falciparum [1]. The burden of malaria mortality now and in recent human evolutionary history has been greatest in children under the age of five years, consistent with the notion that malaria has had a powerful effect on selection of the human genome. Indeed, based on observations of the geographic overlap between malaria endemicity and the frequency of erythroid variants such as thalassaemia, Haldane hypothesized in the mid 20th century that such polymorphisms were under selective pressure, because they were protective against severe malaria infection and thereby increased the reproductive fitness of individuals living in malaria endemic areas [2,3].
###end p 11
###begin p 12
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 362 373 362 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycoplasma </italic>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 528 533 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 676 681 676 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 833 835 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 905 906 901 902 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n</sub>
###xml 1146 1148 1142 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1149 1151 1145 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1249 1258 1245 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1259 1261 1255 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1306 1310 1302 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2</italic>
###xml 1374 1376 1370 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1478 1487 1474 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1488 1490 1484 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1581 1583 1577 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1584 1586 1580 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1589 1611 1585 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 1641 1642 1637 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1733 1735 1729 1731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1736 1738 1732 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1760 1765 1756 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4 </italic>
###xml 1909 1911 1905 1907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1912 1914 1908 1910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 2013 2015 2009 2011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 2119 2120 2115 2116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 2178 2187 2174 2183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 2205 2207 2201 2203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 2228 2230 2224 2226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 2231 2233 2227 2229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 2363 2365 2359 2361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 2366 2368 2362 2364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 2457 2459 2453 2455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 2460 2462 2456 2458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 2465 2470 2461 2466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 2554 2556 2550 2552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 2565 2570 2561 2566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 2667 2669 2663 2665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 2875 2877 2871 2873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 2878 2880 2874 2876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 2888 2893 2884 2889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4 </italic>
###xml 2907 2912 2903 2908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 3013 3015 3009 3011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 3192 3194 3188 3190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 3195 3197 3191 3193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 3567 3568 3563 3564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 3659 3661 3655 3657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 3787 3789 3783 3785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 3895 3904 3891 3900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 3905 3906 3901 3902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 226 231 <span type="species:ncbi:9606">human</span>
###xml 1589 1610 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 2028 2036 <span type="species:ncbi:9606">children</span>
Toll-like receptors are innate immune receptors that bind to conserved structural motifs expressed by microbial pathogens. TLR2, TLR4, TLR9, and downstream signaling pathways of these proteins have recently been implicated in human malaria pathogenesis [4-6]. TLR2 is expressed on the cell surface, where it is activated by bacterial lipopeptides and fungal and Mycoplasma ligands [7-9]. Malaria-derived glycosylphosphatidylinositol (GPI) has been identified as a potential malaria "toxin" by activating TLR2 signaling [5]. The TLR2 gene is located on chromosome 4q32 and is comprised of 3 exons, which encode 784 amino acids [10,11]. A 22 bp insertion/deletion polymorphism (TLR2 Delta22) in the first untranslated exon was observed to be highly polymorphic in a Japanese population but was not associated with a disease phenotype [12]. A GT dinucleotide that varies by approximately 12 to 30 repeats (GTn) is present within the second intron, approximately 100 bp upstream of the translational start site. Repeats of varying length have been associated with susceptibility to tuberculosis, reversal reactions in leprosy, and colorectal cancer [13-15]. Shorter repeats are associated with reduced TLR2 reporter activity and TLR2 surface expression in vitro [13]. A non-synonymous SNP in the third exon of TLR2, Arg753Gln, is associated with susceptibility to tuberculosis [16], and presumably because of its location in the intracellular domain, abolishes downstream signaling in vitro [17]. TLR4 is expressed on the cell surface and is activated by bacterial lipopolysaccharide [18,19]. Plasmodium falciparum GPI may weakly activate TLR4 [5]. The gene is on chromosome 9q32-q33, consists of 4 exons, and spans approximately 19 kb [10,20]. Two non-synonymous TLR4 SNPs (Asp299Gly and Thr399Ile) are in the extracellular domain, and commonly co-segregate in European Caucasian but not in African populations [21,22]. These SNPs have been associated with various infectious and inflammatory diseases (reviewed in [22]). Ghanaian children with the Asp299Gly and Thr399Ile alleles had an increased risk of severe malaria [4]. These TLR4 mutations confer a hyporesponsive phenotype in vitro in some studies, [23] but not in others [22,24]. TLR9 is expressed in endosomal compartments, where it binds to and is activated by bacterial DNA with unmethylated CpG motifs [25,26]. Malaria haemozoin and/or parasite DNA have been identified as potential TLR9 ligands [27,28]. TLR9 spans 5 kb on chromosome 3p21.3, consists of 2 exons, and encodes 1028 amino acids [29]. Three TLR9 SNPs are present at approximately 15% or greater allele frequency in North American populations [30]. Two of these SNPs, -1486T/C and -1237T/C, are located within the promoter; 1174G/A is in the intron. TLR9 -1237 T/C has been associated with susceptibility to Crohn's Disease, atopic eczema, and asthma [31-33]. Both TLR4 Asp299Gly and TLR9 -1486T/C were associated with low birth weight and maternal anaemia in a malaria endemic population [34]. MAL (also known as Toll-Interleukin-1 Receptor domain-containing Adaptor Protein, TIRAP) is a downstream adaptor protein common to both the TLR2 and TLR4 signaling pathways [35,36]. The gene spans 14.5 kb on chromosome 11q24.2, consists of 8 exons, and encodes a 221 amino acid protein. Individuals heterozygous for a Ser/Leu mutation at amino acid 180 were reported to be protected from invasive pneumococcal disease, bacteraemia, malaria, and tuberculosis in an analysis of several case-control studies conducted in the UK and sub-Saharan Africa [6]. A subsequent study found protection against tuberculosis in a population of Colombians [37], but no protection was revealed in an analysis comparing tuberculosis cases and controls from Russia, Ghana, and Indonesia [38]. The Ser to Leu amino acid change abolishes the ability of TLR2 to recruit MAL for downstream signaling in vitro [6].
###end p 12
###begin p 13
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR </italic>
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 602 605 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 765 775 765 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2, 4, 9</italic>
###xml 781 785 781 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
The hypothesis of this study was that the above TLR and MAL genes are under selective pressure by malaria and therefore, that the frequencies of the SNPs observed in these genes would vary significantly among populations historically and currently exposed to differing levels of malaria transmission and morbidity. For example, in the two Kenyan study sites examined here, the frequencies of sickle cell trait and G6PD deficiency are significantly greater in the holoendemic site compared to the episodic transmission site [39], where malaria transmission was introduced during the first half of the 20th century [40,41]. To test this hypothesis, residents living in areas of varying malaria endemicity in sub-Saharan Africa and Papua New Guinea were genotyped for TLR2, 4, 9, and MAL polymorphisms. Furthermore, in order to put these data in the context of innate immune polymorphisms of populations with no recent history of malaria exposure, North Americans of self-identified ethnicity were also analyzed.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study populations
###end title 15
###begin p 16
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR </italic>
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1242 1244 1242 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1565 1576 1565 1576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 1585 1599 1585 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1956 1958 1956 1958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 572 584 <span type="species:ncbi:9606">participants</span>
###xml 818 824 <span type="species:ncbi:9606">person</span>
###xml 1305 1311 <span type="species:ncbi:9606">people</span>
###xml 1585 1598 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1874 1880 <span type="species:ncbi:9606">person</span>
###xml 2012 2020 <span type="species:ncbi:9606">children</span>
TLR and MAL genetic polymorphisms were evaluated in 170 individuals from Kenya, 346 individuals from Papua New Guinea, and 261 North Americans of self identified ethnicity (total n = 777). Kenyan and Papua New Guinean study population characteristics in terms of age structure and malaria infection prevalence are presented in additional file 1 (table S1). The samples from Kenyans were collected from residents of two villages in the western part of the country, Kanyawegi (n = 91) and Kipsamoite (n = 79), as part of an earlier immunoepidemiologic study [42]. All study participants were asymptomatic with no malaria-related illness when blood for genotyping was obtained. Malaria transmission in the lowland area of Kanyawegi is holoendemic. Annual entomologic inoculation rates may exceed 300 infectious bites per person [43]. Kipsamoite is located in a highland area in the Nandi district of Rift Valley Province where malaria transmission is unstable and characterized by periods with extremely low malaria infection prevalence [44]. During the course of this study, uncomplicated malaria cases peaked in Nandi during the months of May to August, during which time approximately 200 cases were reported by the Kipsamoite Health Center [44]. The 346 Papua New Guinean DNA samples were collected from people of the Urat and Urim linguistic groups in the Dreikikir district of East Sepik Province. These individuals were enrolled in a study examining mass drug administration to eliminate filariasis. During the course of the study, infection rates with various Plasmodium spp. and P. falciparum asexual densities were obtained. All individuals were asymptomatic with no known episodes of severe malaria morbidity. Malaria transmission is perennial and stable in this area of Papua New Guinea. The entomologic inoculation rate is estimated to be 0.9 infectious bites per person per night, a transmission intensity similar to the holoendemic Kenya site [45]. Mild malaria in this area has a peak prevalence in children less than 5 years old, and severe malaria is most frequently manifested as severe anaemia. DNA from de-identified North American adults was obtained from the National Histocompatibility Laboratory, American Red Cross/University of Maryland Medical System, Baltimore, MD. Race and ethnicity of the North Americans were self-identified. The population was heterogeneous - Asian American (n = 84), Caucasian American of European ancestry (n = 84), and African American (n = 93).
###end p 16
###begin p 17
###xml 149 154 <span type="species:ncbi:9606">Human</span>
Informed consent, blood sample collection, and genotyping were performed under protocols approved by the Ethical and Institutional Review Boards for Human Investigation at the Kenya Medical Research Institute, the Medical Research Advisory Committee of the Papua New Guinea Department of Health, and University Hospitals of Cleveland/Case Western Reserve University.
###end p 17
###begin title 18
Polymerase chain reaction (PCR)
###end title 18
###begin p 19
###xml 188 189 187 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 221 225 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 339 340 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 436 441 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 540 545 534 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 547 549 541 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n </sub>
###xml 673 675 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
Genomic DNA was extracted from blood using the QIAamp 96 spin blood kit (QIAGEN, Valencia, CA). PCR was performed using a master mix consisting of 1x PCR buffer, 125 muM dNTPs, 2.5 mM MgCl2, 125 nM primers, and 0.8 units Taq polymerase in a reaction volume of 25 mul. PCR primers and amplification conditions are listed in additional file 2 (table S2). PCR products for SNP detection were analyzed on a 2% agarose gel prior to LDR-FMA. TLR2 Delta 22 genotypes were assigned based on size discrimination of PCR products on a 4% agarose gel. TLR2 GTn genotypes were assigned based on size discrimination of PCR products run on a 6% polyacrylamide gel as described elsewhere [46]
###end p 19
###begin title 20
Cloning and sequencing
###end title 20
###begin p 21
PCR amplification products from local donors were purified using the QIAquick PCR purification kit (QIAGEN, Valencia, CA). Purified PCR products were sent to MWG Biotech, High Point, NC for sequencing. Sequences were analyzed using the Sequencher software (Gene Codes Corporation, Ann Arbor, MI). Sequenced DNA templates were subjected to PCR and used in the LDR-FMA as positive controls.
###end p 21
###begin title 22
SNP genotyping
###end title 22
###begin p 23
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
PCR products were analyzed in a LDR-FMA divided into 3 steps: (1) ligation of oligonucleotides to the SNP, (2) FlexMAP microsphere hybridization, and (3) detection using the Bioplex suspension array system, which includes a fluorescence reader and the Bio-Plex Manager analytical software (Bio-Rad Laboratories, Hercules, CA). This procedure is described in detail elsewhere [47]. Conserved and allele-specific probe sequences are listed in additional file 3 (table S3).
###end p 23
###begin p 24
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2</italic>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9</italic>
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4 </italic>
###xml 284 286 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
A multiplex assay was used for simultaneous detection of TLR2, TLR9, and MAL SNPs. TLR4 SNPs were evaluated in a separate multiplexed LDR. Equal volumes of each PCR product were mixed, and 1 mul was added to the LDR. Conditions for the LDR step of this assay are described elsewhere [47].
###end p 24
###begin title 25
Statistical analysis
###end title 25
###begin p 26
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n</sub>
###xml 219 220 219 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n</sub>
###xml 515 517 515 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n </sub>
###xml 522 524 522 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n </sub>
###xml 732 733 732 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
Mean Fluorescence Intensity (MFI) values were used to calculate the allelic ratio for each SNP by dividing the allele-specific MFI value by the sum of the MFI values for that SNP (allele A/A+B = An, and allele B/A+B = Bn), where A and B are the 2 alleles of a SNP. To be homozygous for a particular allele, the ratio must be > 0.75. To be heterozygous, the ratio of the 2 alleles must be between 0.25 and 0.75. Consequently, an allele included in a ratio of < 0.25 is considered not present. Normalized values for An and Bn were divided, and the quotient was log-transformed. The mean and 95% confidence interval (CI) of the log-transformed quotients for the 777 individuals genotyped in this study are presented in additional file 4 (table S4).
###end p 26
###begin p 27
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
Allele (or haplotype) and genotype (diplotype) frequencies were calculated for the different polymorphisms, the Hardy-Weinberg exact test (estimation of p-values by the Markov chain method), and the Ewens-Watterson homozygosity test was performed for each population using Arlequin version 3.01 . Differences in allele frequencies among study groups were determined by chi-square analysis using SPSS for Windows (version 13.0). A p-value < 0.05 was considered to be significant. Statistical comparisons of allele frequencies were made between the following groups; Kenya malaria holoendemic vs. Kenya episodic transmission: each of the Kenyan study populations vs. African American, Kenya holoendemic vs. Papua New Guinea holoendemic, and Papua New Guinea holoendemic vs. Asian Americans. Linkage disequilibrium analysis was performed using SHEsis [48].
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2</italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4</italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9</italic>
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 106 111 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 113 115 109 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n </sub>
Table 1 describes the mutant allele frequencies for the TLR2, TLR4, TLR9, and MAL SNPs, TLR2 Delta22, and TLR2 GTn polymorphisms in the populations from Kenya, Papua New Guinea, and North America.
###end p 29
###begin p 30
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2, 4, 9</italic>
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
TLR2, 4, 9, and MAL mutant allele frequencies in various populations
###end p 30
###begin p 31
GTS < 16 repeats, GTM 16-23 repeats, GTL > 23 repeats.
###end p 31
###begin p 32
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">I</sup>
Ip < 0.05, compared with Kenyan lowlands
###end p 32
###begin p 33
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">II</sup>
IIp < 0.05 compared to African Americans
###end p 33
###begin p 34
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">III</sup>
IIIp = 0.062 compared to African Americans
###end p 34
###begin p 35
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">IV</sup>
IVp = 0.067 compared to African Americans
###end p 35
###begin p 36
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">V</sup>
###xml 20 22 20 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
Vtested previously [50]
###end p 36
###begin p 37
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">VI</sup>
VIp < .005 compared to PNG
###end p 37
###begin title 38
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
TLR2 polymorphisms
###end title 38
###begin p 39
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 513 525 <span type="species:ncbi:9606">participants</span>
The TLR2 Delta22 polymorphism in the 5' untranslated region was present in all populations examined at an allele frequency >10%. The lowest value was in Papua New Guineans (13.1%), compared with 32.6% for the Kenyan episodic transmission site. Although the holoendemic Kenyan and Papua New Guinea sites have similar malaria transmission intensities, this allele was significantly less common in Papua New Guinea compared to the Kenya holoendemic site (p < 0.001). Allele frequencies were similar for Kenyan study participants from the holoendemic and episodic transmission sites.
###end p 39
###begin p 40
###xml 6 8 6 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n </sub>
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
The GTn repeat in the 5' untranslated region of TLR2 was highly polymorphic in all populations examined. Consistent with how this genetic variation has been analyzed previously [13,49], the alleles were classified as short (<16), medium (16-23), and long (>23) repeats. The distribution of the length of the repeat is displayed in Figure 1, and frequencies of the allele are presented in Table 1. The medium length allele accounted for >50% of total alleles in all populations with the exception of Asian Americans, where it was 39.4%.
###end p 40
###begin p 41
###xml 0 106 0 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Frequency of GT repeat polymorphism (GTn) among residents of malaria endemic and malaria non-endemic areas</bold>
Frequency of GT repeat polymorphism (GTn) among residents of malaria endemic and malaria non-endemic areas.
###end p 41
###begin p 42
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
A previous report showed that the TLR2 SNP Arg753Gln is absent in Urat and Urim speakers from Papua New Guinea [50]. Therefore, this SNP was not tested here. Arg753Gln was also absent in Kenyans but present in North Americans, consistent with previous reports [51].
###end p 42
###begin title 43
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4</italic>
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9</italic>
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
TLR4, TLR9, and MAL SNP allele frequencies
###end title 43
###begin p 44
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4 </italic>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 696 701 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 775 779 775 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
The two TLR4 SNPs examined in this study are absent in the Urat and Urim linguistic groups in Papua New Guinea [50] and therefore, were not tested here. The predicted Asp299Gly and Thr399Ile amino acid mutations were present at frequencies that were not statistically different for the Kenyans residing in the malaria holoendemic and episodic transmission areas (range 0.7-7.1%). With the exception of -1237C in Papua New Guineans and Asian Americans, all TLR9 SNPs were present at a frequency greater than 10%. Both -1486T/C and 1174G/A were more common in Papua New Guinea compared to the Kenya holoendemic site (p = 0.026 and p < 0.001, respectively). There were no significant differences in TLR9 SNP frequencies associated with different malaria exposures in Kenya. The MAL 180 mutant allele was most common in Papua New Guineans (14.9%). In contrast, this allele was completely absent in the holoendemic Kenyan transmission site, and present in only 2.5% in the episodic transmission site.
###end p 44
###begin title 45
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2</italic>
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR 4</italic>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9</italic>
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
Frequencies of TLR2, TLR 4, TLR9, and MAL genotypes
###end title 45
###begin p 46
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 57 61 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4</italic>
###xml 63 67 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9</italic>
###xml 77 81 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 106 111 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 204 214 196 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4, TLR9</italic>
###xml 220 224 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 474 478 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
Table 2 shows the genotype frequencies for TLR2 Delta22, TLR4, TLR9, and the MAL polymorphisms. All three TLR2 Delta22 genotypes were found in all populations, and were in Hardy-Weinberg equilibrium. The TLR4, TLR9, and MAL SNPs were in Hardy-Weinberg equilibrium in both Kenya and Papua New Guinea. In contrast to Papua New Guineans where -1237C was absent, this allele was present in Asian Americans, for whom there were fewer heterozygotes than expected (p = 0.022). The MAL genotypes were in Hardy-Weinberg equilibrium in all populations except in African Americans, where there was a deficit of heterozygosity (p = 0.02).
###end p 46
###begin p 47
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2, 4, 9</italic>
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
TLR2, 4, 9, and MAL genotypes in various populations
###end p 47
###begin p 48
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">I</sup>
Ino.(%)
###end p 48
###begin p 49
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">II</sup>
IID is deletion allele, W is wild type/insertion allele
###end p 49
###begin p 50
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">III</sup>
IIIp < .05, Hardy-Weinberg test of equilibrium, deficit of heterozygosity
###end p 50
###begin p 51
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">IV</sup>
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
IVgenotyped previously [50]
###end p 51
###begin title 52
Inferred haplotypes and linkage disequilibrium
###end title 52
###begin p 53
###xml 38 48 38 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2, TLR4</italic>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 414 416 414 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 484 489 484 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4 </italic>
###xml 645 647 645 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 679 684 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4 </italic>
###xml 1073 1078 1073 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 1205 1210 1205 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 1379 1384 1379 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
Statistically inferred haplotypes for TLR2, TLR4, and TLR9 are described in Table 3. Of six possible TLR2 haplotype combinations, all were present in Papua New Guineans and North Americans. The deletion allele did not co-segregate with any of the GT repeat length alleles, as determined in linkage disequilibrium analysis where two polymorphisms were considered in linkage disequilibrium if the values for D' and r2 were >0.9 (data not shown). The Asp299Gly and Thr399Ile SNPs in the TLR4 gene commonly co-segregated in Caucasian Americans. Consistent with these data, the two polymorphisms were in linkage disequilibrium as measured by D' and r2 (data not shown). In Kenya, the TLR4 mutations co-segregated less frequently, and the Gly-Thr haplotype was present at 5-6% frequency in both the episodic transmission and holoendemic study sites. This haplotype was also found in African Americans and Asian Americans. There was no linkage disequilibrium between Asp299Gly and Thr399Ile in the Kenyans, African Americans, or Asians Americans (data not shown). The most common TLR9 haplotypes were CTG and TTA, except in Kenyans and African Americans, where TCG and TTA were the most common. There were fewer TLR9 haplotypes present in Papua New Guineans compared to the other populations, largely due to the absence of the -1237 allele. There was linkage disequilibrium between all TLR9 SNP pairs present in Papua New Guineans (data not shown). This linkage disequilibrium was absent in the Kenyan and Asian American populations.
###end p 53
###begin p 54
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2, TLR4</italic>
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
TLR2, TLR4, and TLR9 haplotypes in various populations
###end p 54
###begin p 55
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">I</sup>
###xml 11 13 7 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n </sub>
IDelta22-GTn haplotypes
###end p 55
###begin p 56
D is deletion allele, W is wild type
###end p 56
###begin p 57
S < 16 repeats, M 16-23 repeats, L > 23 repeats.
###end p 57
###begin p 58
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">II</sup>
IIFirst amino acid is 299, second amino acid is 399
###end p 58
###begin p 59
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">III</sup>
IIIFirst nucleotide is -1486, second is -1237, and third is 1174.
###end p 59
###begin p 60
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">IV</sup>
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
IVGenotyped previously [50]
###end p 60
###begin title 61
Discussion
###end title 61
###begin p 62
###xml 585 587 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
There is compelling evidence that evolution of the human genome has involved selective pressure exerted by microbial pathogens. Perhaps one of the best characterized examples of this natural selection process is historical exposure to falciparum malaria and its' association with the beta-globin SNP underlying the haemoglobin S sickle cell trait. The frequency of this mutant allele (and other beta-globin variants such as haemoglobin C) is greater than 25% in populations in Sub-Saharan Africa where it has been observed to mediate a strong protective effect against severe malaria [52]. Data reported here provide information relevant to the growing interest in understanding how innate immunity may contribute to malaria susceptibility. Information on the genetics of innate immunity should help define the basis of individual and population variation in susceptibility to malaria pathogenesis and may facilitate efforts to develop vaccines, vaccine adjuvants, and treatments to fight this infectious disease.
###end p 62
###begin p 63
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2</italic>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4</italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 146 155 146 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 565 566 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 621 625 621 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR </italic>
###xml 628 632 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 999 1003 999 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR </italic>
###xml 1006 1010 1006 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 1118 1122 1118 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 1357 1358 1355 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1506 1507 1504 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1760 1761 1758 1759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 91 96 <span type="species:ncbi:9606">human</span>
This study focused on TLR2, TLR4, TLR9 and MAL because these genes have been implicated in human malaria pathogenesis. Evidence for this includes in vitro experiments in which engagement of the immune receptor by putative malaria toxins and activation of downstream signaling pathways lead to production of pro-inflammatory cytokines [5,27,28], and from case-control studies in which the frequencies of selected polymorphisms among individuals with severe malaria illness are compared with those of ethnically and age-matched residents with asymptomatic malaria [4,6]. The results presented here suggest that none of the TLR or MAL polymorphisms examined have been under strong selective pressure by malaria. Although the protective haemoglobin S and G6PD polymorphisms are significantly more common in Kenyan residents of the malaria holoendemic area compared to residents of the nearby episodic low transmission area [39], statistically significant differences in mutant allele frequencies of the TLR or MAL polymorphisms were not detected. A notable finding in the Papua New Guinea population is concerned with the MAL SNP that confers a Ser-->Leu amino acid change. The mutation abrogates downstream signaling following ligand engagement of TLR2 and TLR4. The frequency of the mutant allele in the Papua New Guinea population was high (14.9%, see Table 1) compared to the other populations. Moreover, identification of homozygous individuals for the mutant Leu allele (11 of 254 individuals, see Table 2) is of potential interest since previous studies have suggested that heterozygosity affords protection against not only malaria but also bacterial infections. Homozygosity for this allele has not been observed in African populations (e.g. Khor, et al [6] reported no homozygous individuals among the 4902 West and East Africans genotyped in their study.) Third, all of the polymorphisms in malaria endemic populations studied here were in Hardy-Weinberg equilibrium, suggesting that selective pressure by malaria (or other population-wide effects such as bacterial infection, starvation, population size, non-random mating, etc), has not affected the frequency and distribution of the allele. Additionally, these alleles followed the Neutral Theory as determined by a p-value < 0.05 for the Ewens-Watterson test of homozygosity. For the polymorphisms examined in these study populations, the frequency of observed homozygotes was not significantly different than the homozygote frequency expected under the Neutral Theory. This suggests that genetic drift rather than natural selection, by malaria or any other agent, has been more significant in determining these allele frequencies.
###end p 63
###begin p 64
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4 </italic>
###xml 660 671 660 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-B*5301 </italic>
###xml 675 689 675 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1*1302 </italic>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 809 813 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF </italic>
###xml 817 824 817 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ICAM-1 </italic>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1338 1347 1338 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 1360 1362 1360 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1488 1490 1488 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 1338 1346 <span type="species:ncbi:5855">P. vivax</span>
###xml 1387 1390 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1463 1466 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The lack of difference in the frequency of these polymorphisms among populations with varying levels of malaria endemicity may be because these innate immune pathways truly do not alter susceptibility to severe malaria. However, it is important to recognize alternative explanations. The number of individuals sampled may be insufficient to detect statistically small but biologically meaningful differences. Whereas MAL Ser180Leu and the TLR4 SNPs in other populations have respectively, been associated with protection and susceptibility to malaria, these associations may not exist in the Kenyan or Papua New Guinean populations examined here. For example, HLA-B*5301 and HLA-DRB1*1302 were associated with resistance to severe malaria in Gambia [53], whereas this association was not found in Kenya [54]. TNF and ICAM-1 polymorphisms and their association with malaria susceptibility has also been inconsistent across various populations (reviewed in [52]). Other counter-selective forces in these populations also may be acting to limit the spread of the polymorphisms in the genes studied here. Polymorphisms that are protective against malaria may increase the risk of non-malarial infectious diseases. For example, recently it was demonstrated that Duffy blood group-negativity, which confers complete protection from blood stage P. vivax in Africans [55], increases the risk of HIV infection in African Americans and may also contribute to the burden of HIV infection in Africa [56]. Because TLRs and their downstream adaptor proteins are critical in the responses to different pathogens, it is likely that similarly complex selective pressures act on these genes.
###end p 64
###begin p 65
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR</italic>
###xml 279 283 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2</italic>
###xml 405 407 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 414 423 410 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 451 453 443 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n </sub>
###xml 752 765 744 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 779 780 771 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 752 765 <span type="species:ncbi:5833">P. falciparum</span>
This study is the first to describe the TLR2 5' untranslated polymorphisms in Kenyans and Papua New Guineans from malaria endemic areas. These polymorphisms presumably affect transcription and/or translation. The Delta22 polymorphism is located in the first untranslated exon of TLR2, approximately 60 bp downstream of an NF-kB site critical for chromatin remodeling and binding of transcription factors [57]. The in vitro phenotypes of Delta22 and GTn need to be investigated more thoroughly to determine their effect on mRNA transcription and/or translation. Although these polymorphisms have not been studied in malaria case-control studies, TLR2 is potentially involved in the pathogenesis of malaria because of its putative role as a receptor for P. falciparum-derived GPI [5].
###end p 65
###begin p 66
###xml 470 479 470 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a priori </italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 229 235 <span type="species:ncbi:9606">humans</span>
Future studies with larger sample sizes, additional SNPs, and other genetic loci are needed to determine more completely whether falciparum malaria has been involved in natural selection of genes that regulate innate immunity in humans. Advances in analytic and molecular tools such as tagged SNPs, such as those now available in the International HapMap project, also make it possible to identify signatures of natural selection in these and other genetic loci without a priori knowledge of their biologic function and contribution to malaria pathogenesis [58].
###end p 66
###begin title 67
Conclusion
###end title 67
###begin p 68
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR </italic>
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR </italic>
###xml 228 235 228 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2, 4</italic>
###xml 241 243 241 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">9 </italic>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAL </italic>
###xml 518 523 <span type="species:ncbi:9606">human</span>
The goal of this study was to identify TLR and TLR adaptor polymorphisms under selective pressure by malaria. The data suggest that history of malaria exposure of the two Kenyan populations has not been involved in selection of TLR2, 4, and 9 or MAL polymorphisms. Case-control studies comparing the frequencies of these polymorphisms among individuals with severe malaria with those with asymptomatic malaria infection need to be conducted to define more completely the potential role of these innate immune genes in human malaria pathogenesis.
###end p 68
###begin title 69
Competing interests
###end title 69
###begin p 70
The authors declare that they have no competing interests.
###end p 70
###begin title 71
Authors' contributions
###end title 71
###begin p 72
JG performed and analyzed genotyping assays and drafted manuscript. JK conceived of the study, participated in its design and helped draft the manuscript. PZ participated in the design of the genotyping strategy and assisted in the analysis of the genotyping data. AM, JV, and MB were involved in collection of samples and the design of population-based field studies and helped write the manuscript.
###end p 72
###begin title 73
Supplementary Material
###end title 73
###begin title 74
Additional file 1
###end title 74
###begin p 75
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Malariometric characteristics of Kenyan and Papua New Guinean study subjects.</bold>
###xml 179 191 <span type="species:ncbi:9606">participants</span>
Malariometric characteristics of Kenyan and Papua New Guinean study subjects. This file contains age, sex, and parasitaemia information for the Kenyan and Papua New Guinean study participants.
###end p 75
###begin p 76
Click here for file
###end p 76
###begin title 77
Additional file 2
###end title 77
###begin p 78
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PCR primers and amplification conditions.</bold>
PCR primers and amplification conditions. This file contains sequences for the PCR primers used and amplification conditions.
###end p 78
###begin p 79
Click here for file
###end p 79
###begin title 80
Additional file 3
###end title 80
###begin p 81
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">LDR-FMA primers for SNP genotyping.</bold>
LDR-FMA primers for SNP genotyping. This file contains the oligonucleotide sequences for the LDR-FMA reaction, as well as the SNPs examined and their accession number.
###end p 81
###begin p 82
Click here for file
###end p 82
###begin title 83
Additional file 4
###end title 83
###begin p 84
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mean and 95% confidence interval (CI) values of allelic ratios to determine genotypes.</bold>
Mean and 95% confidence interval (CI) values of allelic ratios to determine genotypes. This file contains the mean and 95% confidence intervals of the MFI values from the LDR-FMA reaction used to determine genotypes.
###end p 84
###begin p 85
Click here for file
###end p 85
###begin title 86
Acknowledgements
###end title 86
###begin p 87
We thank Rajeev Mehlotra and Amy Hise for critical reading and discussion of the manuscript. We thank Daniel Tisch for his help with the Papua New Guinea database. Susan Wherley helped genotype some of the North American samples.
###end p 87
###begin article-title 88
Cerebral malaria
###end article-title 88
###begin article-title 89
###xml 25 30 <span type="species:ncbi:9606">Human</span>
The Rate of Mutations of Human Genes
###end article-title 89
###begin article-title 90
Disease and evolution
###end article-title 90
###begin article-title 91
###xml 50 58 <span type="species:ncbi:9606">children</span>
Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria
###end article-title 91
###begin article-title 92
###xml 94 115 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity
###end article-title 92
###begin article-title 93
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis
###end article-title 93
###begin article-title 94
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors
###end article-title 94
###begin article-title 95
Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products
###end article-title 95
###begin article-title 96
Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway
###end article-title 96
###begin article-title 97
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 52 62 <span type="species:ncbi:7227">Drosophila</span>
A family of human receptors structurally related to Drosophila Toll
###end article-title 97
###begin article-title 98
###xml 34 39 <span type="species:ncbi:9606">human</span>
Transcriptional regulation of the human toll-like receptor 2 gene in monocytes and macrophages
###end article-title 98
###begin article-title 99
An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population
###end article-title 99
###begin article-title 100
###xml 73 78 <span type="species:ncbi:9606">human</span>
The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans
###end article-title 100
###begin article-title 101
Microsatelite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancer
###end article-title 101
###begin article-title 102
Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy
###end article-title 102
###begin article-title 103
###xml 34 39 <span type="species:ncbi:9606">human</span>
The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease
###end article-title 103
###begin article-title 104
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 80 100 <span type="species:ncbi:139">Borrelia burgdorferi</span>
Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease
###end article-title 104
###begin article-title 105
Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction
###end article-title 105
###begin article-title 106
###xml 52 56 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product
###end article-title 106
###begin article-title 107
###xml 94 99 <span type="species:ncbi:9606">human</span>
PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene
###end article-title 107
###begin article-title 108
###xml 94 100 <span type="species:ncbi:9606">humans</span>
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans
###end article-title 108
###begin article-title 109
###xml 55 60 <span type="species:ncbi:9606">human</span>
Toll-like receptor polymorphisms and susceptibility to human disease
###end article-title 109
###begin article-title 110
###xml 67 73 <span type="species:ncbi:9606">humans</span>
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
###end article-title 110
###begin article-title 111
Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling
###end article-title 111
###begin article-title 112
TLR9 signals after translocating from the ER to CpG DNA in the lysosome
###end article-title 112
###begin article-title 113
A Toll-like receptor recognizes bacterial DNA
###end article-title 113
###begin article-title 114
Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9
###end article-title 114
###begin article-title 115
Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin
###end article-title 115
###begin article-title 116
Three novel mammalian toll-like receptors: gene structure, expression, and evolution
###end article-title 116
###begin article-title 117
Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies
###end article-title 117
###begin article-title 118
Crohn's disease is associated with a toll-like receptor-9 polymorphism
###end article-title 118
###begin article-title 119
Putative association of a TLR9 promoter polymorphism with atopic eczema
###end article-title 119
###begin article-title 120
###xml 90 98 <span type="species:ncbi:9606">children</span>
Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children
###end article-title 120
###begin article-title 121
Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy
###end article-title 121
###begin article-title 122
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction
###end article-title 122
###begin article-title 123
Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4
###end article-title 123
###begin article-title 124
TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus
###end article-title 124
###begin article-title 125
Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations
###end article-title 125
###begin article-title 126
Frequencies of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency differ in highland and nearby lowland malaria-endemic areas of Kenya
###end article-title 126
###begin article-title 127
Clinical epidemiology of malaria in the highlands of western Kenya
###end article-title 127
###begin article-title 128
Reemergence of epidemic malaria in the highlands of western Kenya
###end article-title 128
###begin article-title 129
###xml 30 51 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria
###end article-title 129
###begin article-title 130
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya
###end article-title 130
###begin article-title 131
###xml 18 39 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Low prevalence of Plasmodium falciparum infection among asymptomatic individuals in a highland area of Kenya
###end article-title 131
###begin article-title 132
###xml 81 87 <span type="species:ncbi:9606">humans</span>
The late biting habit of parous Anopheles mosquitoes and pre-bedtime exposure of humans to infective female mosquitoes
###end article-title 132
###begin article-title 133
Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New Guinea
###end article-title 133
###begin article-title 134
Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea
###end article-title 134
###begin article-title 135
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci
###end article-title 135
###begin article-title 136
###xml 45 50 <span type="species:ncbi:9606">human</span>
A microsatellite polymorphism in intron 2 of human Toll-like receptor 2 gene: functional implications and racial differences
###end article-title 136
###begin article-title 137
Polymorphisms of innate immunity genes and susceptibility to lymphatic filariasis
###end article-title 137
###begin article-title 138
High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR
###end article-title 138
###begin article-title 139
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
How malaria has affected the human genome and what human genetics can teach us about malaria
###end article-title 139
###begin article-title 140
Common west African HLA antigens are associated with protection from severe malaria
###end article-title 140
###begin article-title 141
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human leukocyte antigens and natural selection by malaria
###end article-title 141
###begin article-title 142
Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals
###end article-title 142
###begin article-title 143
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 121 124 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility
###end article-title 143
###begin article-title 144
###xml 29 34 <span type="species:ncbi:9606">human</span>
Microbial products stimulate human Toll-like receptor 2 expression through histone modification surrounding a proximal NF-kappaB-binding site
###end article-title 144
###begin article-title 145
Searching for signals of evolutionary selection in 168 genes related to immune function
###end article-title 145

